Paper · 42883713
Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research.
Ryznar G and 2 others. Int J Mol Sci, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research. Papers, record 42883713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42883713
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research.
- Journal
- Int J Mol Sci
- Year
- 2026
- Publication types
- Journal Article, Scoping Review
- Revised in PubMed
- 2026-10-20
Source PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factors | Major topic |
| Major Depressive Disorder | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Animals | |
| Humans | |
| Antidepressive Agents | |
| Biomarkers | |
| Signal Transduction | |
| Translational Research, Biomedical |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 503/1-062-02/503-11-001 | Medical University of Lodz | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39,799,156 | Associations between biomarkers of inflammation and depressive symptoms-potential differences between diabetes types and symptom clusters of depression. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/39799156 | PubMed |
| 2 | 22,513,055 | Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression. | Biol Psychiatry | 2012 | https://conductscience.org/library/papers/22513055 | PubMed |
| 3 | 16,861,106 | Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. | Brain Res Bull | 2006 | https://conductscience.org/library/papers/16861106 | PubMed |
| 4 | 41,962,256 | Reduced serum FGF17 levels are associated with deficits in motivation, pleasure, and expression in antidepressant-free patients with major depressive disorder. | Asian J Psychiatr | 2026 | https://conductscience.org/library/papers/41962256 | PubMed |
| 5 | 11,276,432 | Fibroblast growth factors. | Genome Biol | 2001 | https://conductscience.org/library/papers/11276432 | PubMed |
| 6 | 33,445,083 | Fibroblast Growth Factor 2 Implicated in Childhood Anxiety and Depression Symptoms. | J Affect Disord | 2021 | https://conductscience.org/library/papers/33445083 | PubMed |
| 7 | 24,733,629 | Isoforms of receptors of fibroblast growth factors. | J Cell Physiol | 2014 | https://conductscience.org/library/papers/24733629 | PubMed |
| 8 | 23,640,885 | The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). | J Biol Chem | 2013 | https://conductscience.org/library/papers/23640885 | PubMed |
| 9 | 19,586,755 | Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects. | Eur Neuropsychopharmacol | 2009 | https://conductscience.org/library/papers/19586755 | PubMed |
| 10 | 30,583,255 | Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder. | Psychiatry Res | 2019 | https://conductscience.org/library/papers/30583255 | PubMed |
1 to 10 of 121
See all 121 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42883713
GET https://conductscience.org/api/papers/v1/42883713/references?page=2